NCT03514537 - Autologous Stem/Stromal Cellular Stromal Vascular Fraction (cSVF) In Frailty-Aging Processes | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

March 15, 2027

Study Completion Date

January 15, 2028

Conditions

Frail Elderly SyndromeAgingDegenerative Disease

Interventions

PROCEDURE

Microcannula harvest adipose stromal tissues

Use of disposable, closed syringe microcannula harvest autologous adipose stroma and stem/stromal cells

DEVICE

Centricyte 1000

Centricyte 1000, closed system digestion of stromal vascular fraction to isolate and concentrate stem/stromal cells associated with microvasculature

PROCEDURE

Sterile Normal Saline IV Deployment of cSVF

Sterile Normal Saline Suspension cSVF in 500 cc for Intravenous Delivery including 150 micron in-line filtration

DRUG

Liberase

Liberase TM for use to enzymatically isolate cellular stromal vascular fraction

DRUG

Saline Solution

Sterile, Normal Saline 500 for Intravenous use

Trial Locations (1)

Fanny Island Campus Medical Building, Colchester